|
|
Article: Japanese generic drugs market set to grow 17.5% to 356B yen in 2010.
- Article from:
- Pharma Marketletter
- Article date:
- January 19, 2009
CopyrightCOPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The Japanese generic pharmaceuticals market will expand by 17.5% to 359.7 billion yen ($4.03 billion) in 2010 from 306.2 billion yen in 2007, due to government policies to promote the use of copy-cat medicines, including increasing the use of such drugs in hospitals through the introduction of the diagnosis procedure combination or a flat-sum reimbursement system, according to a recent survey conducted by Fuji Keizai, a Tokyo-based market research company.
Generics will account for 5.2% of total prescription medicine turnover in 2020, which will amount to 6,892.9 billion yen, compared with 4.7% of the 6,529.0-billion-yen market in 2007.
High-ratio areas